Morningside Venture Investments is an investment group that provides industry investments and social responsibility.
Business Model:
Revenue: $45.8M
Employees: 51-200
Address: 2-20 Paterson Street
City: Causeway Bay
State: other
Zip:
Country: HK
Morningside Venture Investments is an investment group that provides industry investments and social responsibility. It was founded in 1986 and is based in Shanghai, China.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2021 | Amylyx Pharmaceuticals | Series C | 0 |
10/2021 | Exo Therapeutics | Series B | 0 |
7/2020 | Amylyx Pharmaceuticals | Series B | 0 |
10/2019 | Cognoa | Series A | 45.1M |
2/2022 | Curve Health | Series A | 0 |
6/2017 | Desora | Series A | - |
12/2021 | Almond FinTech | Seed Round | 2M |
1/2019 | Jitjatjo | Series A | 11M |
7/2020 | Vesigen Therapeutics | Series A | 28.5M |
11/2022 | Resilience Lab | Series A | 0 |
11/2004 | ViOptix | Series C | 0 |
11/2021 | ieso | Series B | 0 |
12/2014 | Twelve Springs | Series A | 7M |
9/2019 | Aural Analytics | Seed Round | 0 |
11/2021 | Huckleberry Labs | Series A | 0 |
12/2021 | Almond Finance | Seed | 2M |
9/2019 | ZielBio | Series A | 25.1M |
7/2021 | Fount Bio | Series A | 8.2M |
6/2021 | Alentis Therapeutics | Series B | 66.8M |
4/2019 | Allysta | Series A | - |
11/2018 | Retrotope | Series C | 20M |
4/2019 | CollegeVine | Series B | 24M |
11/2021 | EasyExpunctions | Series A | 6.3M |
3/2021 | Stavvy | Series A | 26.5M |
1/2021 | Innodem Neurosciences | Series A | 6M |
7/2021 | Medrhythms | Series B | 25M |
5/2021 | Neuroelectrics | Series A | 17.5M |
5/2021 | Coin Metrics | Series B | 0 |
2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
9/2019 | Inotrem | Series B | 43.1M |
1/2017 | Lighthouse.io | Seed Round | 0 |
3/2020 | Sensel | Series A | 0 |
1/2021 | New Amsterdam Pharma | Series A | 0 |
3/2021 | Apnimed | Series B | 25M |
5/2021 | Stealth BioTherapeutics | Post-IPO Equity | 30M |
1/2019 | Apic Bio | Series A | 0 |
4/2020 | Stealth BioTherapeutics | Post-IPO Equity | 20M |
7/2019 | Rockley Photonics | Series E | 52M |
1/2020 | Cyted | Seed Round | 10.5M |
9/2019 | Meissa Vaccines | Series A | 30M |
1/2011 | Clean Membranes | Series A | - |
6/2018 | Triastek | Series A | 15.6M |
11/2021 | Generate Biomedicines | Series B | 0 |
11/2021 | Geneoscopy | Series B | 105M |
6/2018 | ENYO Pharma | Series B | 46.8M |
11/2021 | DeepCure | Series A | 0 |
7/2016 | Ignition Design Labs | Series A | 10.3M |
9/2021 | Alamar Biosciences | Series B | 80M |
2/2006 | ThingMagic | Equity | 6M |
7/2021 | Linus Health | Series B | 55M |
3/2021 | Catalant | Venture Round | 35M |
9/2020 | Revolo Biotherapeutics | Series B | 52M |
8/2022 | AdvanCell | Series B | 12.5M |
10/2022 | Valitor | Series B | 0 |
7/2015 | CloudMosa | Series A | 0 |
1/2020 | Adjuvance Technologies | Series A | 20M |
12/2020 | Tallac Therapeutics | Series A | 62M |
8/2017 | Jitjatjo | Seed Round | 4.4M |
1/2022 | Big Health | Series C | 0 |
9/2019 | Medannex Ltd | Series B | 13.5M |
10/2021 | BetterUp | Series E | 0 |
5/2020 | Atea | Series D | 215M |
1/2022 | Casana | Series B | 0 |
1/2022 | Virtue Diagnostics | Series B | 0 |
10/2014 | DNAtriX | Series B | 20M |
9/2021 | Homee | Series B | 0 |
6/2021 | Triastek | Series B | 0 |
11/2016 | CollegeVine | Series A | 3.1M |
8/2020 | Prescryptive Health | Series A | 0 |
10/2020 | CellCentric | Venture Round | 33M |
8/2022 | Epigenic Therapeutics | Seed Round | 0 |
3/2022 | Eko | Series C | 0 |
8/2020 | F2G | Private Equity Round | 0 |
3/2021 | PhoreMost | Series B | 45.3M |
4/2017 | CollegeVine | Series A | 3.6M |
1/2021 | Rockley Photonics | Venture Round | 65M |
7/2020 | neoX Biotech | Venture Round | 10M |
6/2020 | Prilenia | Series A | 62.5M |
2/2020 | Semios | Venture Round | 75M |
9/2020 | Lele Ketang | Series C | 40M |
10/2019 | IM Therapeutics | Series A | 10M |
10/2016 | IrisVR | Series A | 8M |
4/2017 | Freight Farms | Series B | 6.5M |
12/2020 | Curai Health | Series B | 27.5M |
8/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
11/2021 | Block Renovation | Series C | 0 |
8/2017 | Apellis Pharmaceuticals | Series E | 0 |
10/2020 | InCarda Therapeutics | Series C | 30M |
3/2022 | Eko | Series C | 0 |
2/2022 | Curve Health | Series A | 0 |
2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
1/2022 | Casana | Series B | 0 |
1/2022 | Big Health | Series C | 0 |
1/2022 | Virtue Diagnostics | Series B | 0 |
12/2021 | Almond Finance | Seed Round | 0 |
11/2021 | ieso | Series B | 0 |
11/2021 | Generate Biomedicines | Series B | 0 |
11/2021 | Geneoscopy | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|